Skip to content

Efficacy and Safety of Acupuncture for Dizziness and Vertigo in Emergency Department: a Clinical Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02358239
Enrollment
60
Registered
2015-02-06
Start date
2013-02-28
Completion date
2014-02-28
Last updated
2015-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dizziness, Vertigo

Keywords

dizziness and vertigo, emergency department (ED), clinical trial, acupuncture

Brief summary

Dizziness and vertigo account for roughly 4% of chief symptoms in the emergency department (ED). Pharmacological therapy is often solicited for these symptoms, such as vestibular suppressants, anti-emetics and benzodiazepines. However, every medication is accompanied with unavoidable side-effects. To the best of the investigators knowledge, no papers surveyed assess the feasibility of applying acupuncture as an emergent intervention means to the treatment of dizziness and vertigo. The investigators study targeted on filling in this gap by performing a clinical control trial to evaluate the efficacy and safety of traditional Chinese medicine - acupuncture - in treating patients with dizziness and vertigo in ED.

Interventions

PROCEDUREacupuncture

Experiment group received acupuncture at Zusanli (ST36) and Neiguan (PC6) acupuncture points

Sponsors

Po-Chi Hsu
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Visit emergency department and stay in observation unit. * Consult otolaryngologist and neurologist to rule in dizziness and giddiness, auditory vertigo, vertebrobasilar artery syndrome, and peripheral vestibular disorders - Ménière's disease, benign paroxymal peripheral vertigo, and vestibular neuritis.

Exclusion criteria

1. Serious comorbid conditions (for example, life-threatening condition or progressive central disorder). 2. Patients who cannot communicate reliably with the investigator or who are not likely to obey the instructions of the trial.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) of dizzinessafter the first 30 minutes after acupuncture

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026